Myriad Genetics CEO Mark Capone's 2018 pay jumps 35% to $7.1M

Myriad Genetics reports 2018 executive compensation

Published: October 10, 2018

Myriad Genetics reported fiscal year 2018 executive compensation information on October 10, 2018.

In 2018, five executives at Myriad Genetics received on average a compensation package of $3.4M, a 33% increase compared to previous year.

Average pay of disclosed executives at Myriad Genetics

Mark C. Capone, Chief Executive Officer, received $7.1M in total, which increased by 35% compared to 2017. 76.17% of Capone's compensation, or $5.4M, was in stock awards. Capone also received $817.9K in non-equity incentive plan, $852K in salary, as well as $11K in other compensation.

Alexander Ford, President, Myriad Womens Health, Inc, received a compensation package of $2.8M, which increased by 33% compared to previous year. 70.78% of the compensation package, or $2M, was in stock awards.

R. Bryan Riggsbee, Chief Financial Officer, earned $2.6M in 2018, a 33% increase compared to previous year.

Jerry S. Lanchbury, Chief Scientific Officer, received $2.4M in 2018, which increases by 31% compared to 2017.

Richard M. Marsh, General Counsel, earned $2.4M in 2018, a 30% increase compared to previous year.

Myriad Genetics' fiscal year ends on June 30.